Besides the two well-known blood-clotting substances, coagulase and clumping factor, a third one has been identified from the staphylococci which is a cell surface polysaccharide, is alkali stable, and induces compact-colony formation in serum soft agar. Using some 97 clinical strains of Staphylococcus aureus, we found that in production and activity the substances were distinctly different.
We extracted a cell surface polysaccharide from various strains of Staphylococcus aureus (4, 5) that was stable only in alkali and induced compact-colony formation in serum-soft agar medium (6) . This polysaccharide was proposed as the third substance relating to staphylococcal blood clotting, since it converted fibrinogen and its degradation products (6, 7) to fibrin. To increase our knowledge about this compact-colony-forming active substance (CCFAS), we compared its activities with those of coagulase and clumping factor.
For this study we used 97 fresh isolates of S. aureus from the clinical specimens in the Bacteriology Section, St. Marianna University Medical School Hospital. By methods described elsewhere (8), all were found positive for coagulase, deoxyribonuclease, mannitol fermentation, and acid phosphatase. All but two isolates showed a positive clumping factor reaction, as determined by regular procedure, and all but one showed compact-type growth in serum-soft agar, as determined by the method of Finkelstein and Sulkin (2) . The relative coagulase activities of all strains were determined (3) by cultivation in brain heart infusion (Difco) broth at 37°C for 24 h. After centrifugation at 6,000 x g for 20 min, the supernatants were obtained by filtration through a membrane filter (pore size, 0.45 tim; Millipore Corp., Bedford, Mass.). Each supernatant (0.5 ml) was serially diluted with an equal volume of 0.067 M phosphate-buffered saline (pH 7.2). An equal volume (0.5 ml) of saline containing 2 mg of human fibrinogen (KABI, Stockholm, Sweden) was added to each tube. After incubation at 37°C for 8 h, the maximal dilution in which any fibrin clot was macroscopically observed was defined as 1 unit of coagulase activity.
To determine the relative clumping factor activity, the method of Yoshida et al. (9) was followed. Using a stock solution of human fibrinogen (1 mg/ml), we prepared a series of tubes as follows: 1,000, 300, 100, 30, 10, 3, and 1 ,ug/ml. One drop of each dilution was placed on a glass slide and mixed with one loopful of the organisms, which had been grown on brain heart infusion agar plates at 37°C for 18 h. Bacterial clumping observed within 15 s was considered a positive reaction, and the minimal fibrinogen concentration permitting bacterial clumping was expressed as the relative clumping factor activity of the strain.
For the determination of the relative activity of CCFAS, 200 mg of human fibrinogen was dissolved in 1.0 ml of 0.03 M tris(hydroxymethyl)aminomethane-hydrochloride-buffered solution (pH 8.4). This stock solution was serially diluted twofold with the same buffer. A 0.1-ml sample of each dilution was combined with 0.1 ml of a bacterial suspension and mixed into tubes of brain heart infusion soft agar (0.15%) according to the method of Alami and Kelly (1) . After incubation at 37°C for 18 h, colonial morphologies were determined, and the minimal amount of fibrinogen in 1.0 ml of the medium capable of producing definite compact-colony formation was expressed as 1 activity unit of CCFAS. In this case, strains showing diffusetype growth with 2 mg of human fibrinogen per ml in the medium were tentatively regarded as lacking CCFAS activity.
As a result of these experiments (Table 1) , we found that one strain with diffuse-type growth in soft agar, thus lacking CCFAS activity, produced 8 units of coagulase. Moreover, another strain exhibiting a compact-colony type in soft agar, and producing 0.5 unit of CCFAS activity, actually produced 1,024 units of coagulase. On the other hand, three strains developing a compact-colony type in soft agar, and producing 32. shown). Further research concerning the nature of the blood-clotting mechanism of the CCFAS in comparison to coagulase and clumping factor is currently in progress.
